Primit Parikh - 23 Nov 2022 Form 4 Insider Report for Transphorm, Inc. (TGAN)

Role
President and COO
Signature
/s/ Cameron McAulay, Attorney-in-Fact
Issuer symbol
TGAN
Transactions as of
23 Nov 2022
Transactions value $
-$8,942
Form type
4
Filing time
28 Nov 2022, 15:20:55 UTC
Previous filing
21 Nov 2022
Next filing
01 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGAN Common Stock Options Exercise $4.34K +1K +0.42% $4.34 239K 23 Nov 2022 Direct
transaction TGAN Common Stock Sale -$13.3K -2K -0.84% $6.64 237K 23 Nov 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TGAN Stock Option (right to buy) Options Exercise $0 -1K -1.22% $0.00 80.9K 23 Nov 2022 Common Stock 1K $4.34 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale price represents the weighted average sale price of the shares sold ranging from $6.63 to $6.67 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 The shares subject to the option are fully vested and exercisable.